TileDB is foundational software designed by scientists for scientific discovery. TileDB structures all data types, including data that does not fit into relational databases built for structured tabular data.
Built on a powerful shape-shifting array database, TileDB handles the complexities of non-traditional “unstructured” multimodal data, such as genomic variants, bulk and single-cell transcriptomics, proteomics, biomedical imaging, as well as the frontier data of the future. Used by big pharma and biotechs to power their multiomic FAIR data platforms, TileDB is the destination for scientific breakthroughs where frontier multimodal data is driving drug and target discovery.
Investors
Team
Board of Directors
Stavros Papadopoulos
Founder & CEO, TileDB, Inc.
Michael Goguen
Managing Partner, Two Bear Capital
Abhishek Sharma
Managing Director, Nexus Venture Partners
Jorge Colindres
Partner, AlleyCorp
Samuel Madden
Professor, MIT
George Llado
Former SVP and CIO, Alexion. 25 years at Merck in VP-level roles
